Amneal Pharmaceuticals, INC. (AMRX) — 8-K Filings

All 8-K filings from Amneal Pharmaceuticals, INC.. Browse 15 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (15)

Amneal Pharmaceuticals Files 8-K on Financials — Oct 30, 2025 Risk: low
Amneal Pharmaceuticals, Inc. filed an 8-K on October 30, 2025, reporting on its results of operations and financial condition. The filing also includes Regulati
Amneal Pharmaceuticals Enters Material Agreement, Incurs Financial Obligation — Aug 1, 2025 Risk: medium
On August 1, 2025, Amneal Pharmaceuticals, Inc. entered into a material definitive agreement. This filing also indicates the creation of a direct financial obli
Amneal Pharmaceuticals Files 8-K Report — Jul 24, 2025 Risk: low
On July 24, 2025, Amneal Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indica
Amneal Pharmaceuticals Files 8-K on Operations and Personnel — Jul 21, 2025 Risk: low
Amneal Pharmaceuticals, Inc. filed an 8-K on July 21, 2025, reporting on events as of July 16, 2025. The filing covers results of operations, financial conditio
Amneal Pharmaceuticals Files 8-K Report — Jul 21, 2025 Risk: low
On July 21, 2025, Amneal Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with n
Amneal Pharmaceuticals Files 8-K on Shareholder Votes — May 8, 2025 Risk: low
Amneal Pharmaceuticals, Inc. filed an 8-K on May 8, 2025, to report on matters submitted to a vote of its security holders. The filing does not detail the speci
Amneal Pharmaceuticals Files 8-K on Financials — May 2, 2025 Risk: low
Amneal Pharmaceuticals, Inc. filed an 8-K on May 2, 2025, reporting on its Results of Operations and Financial Condition, Regulation FD Disclosure, and Financia
Amneal Pharmaceuticals Reports Director/Officer Changes — Mar 6, 2025 Risk: low
Amneal Pharmaceuticals, Inc. filed an 8-K on March 6, 2025, reporting on the departure of directors, election of directors, appointment of officers, and compens
Amneal Pharmaceuticals Files 8-K on Financials — Jan 15, 2025 Risk: low
Amneal Pharmaceuticals, Inc. filed an 8-K on January 15, 2025, to report results of operations and financial condition, as well as a Regulation FD disclosure. T
Amneal Pharmaceuticals Files 8-K for Q3 2024 Results — Nov 8, 2024 Risk: low
Amneal Pharmaceuticals, Inc. filed an 8-K on November 8, 2024, reporting on its results of operations and financial condition for the period ending September 30
Amneal Pharmaceuticals Files 8-K — Oct 1, 2024 Risk: low
Amneal Pharmaceuticals, Inc. filed an 8-K on October 1, 2024, to report information under Regulation FD and to file financial statements and exhibits. The filin
Amneal Pharmaceuticals Files 8-K on Shareholder Vote — May 7, 2024 Risk: low
Amneal Pharmaceuticals, Inc. filed an 8-K on May 7, 2024, reporting on matters submitted to a vote of security holders on May 2, 2024. The filing does not conta
Amneal Pharmaceuticals Files 8-K on Financials — May 3, 2024 Risk: low
Amneal Pharmaceuticals, Inc. filed an 8-K on May 3, 2024, reporting on its results of operations and financial condition. The filing also includes information r
Amneal Pharmaceuticals Files 8-K on Financials — Mar 1, 2024 Risk: low
Amneal Pharmaceuticals, Inc. filed an 8-K on March 1, 2024, to report on its results of operations and financial condition. The filing also includes Regulation
Amneal Pharma Files 8-K on Operations & Financial Condition — Jan 10, 2024
Amneal Pharmaceuticals, Inc. filed an 8-K on January 10, 2024, to report on its 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure'.

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX